Table 2.
Prior therapies
| 1 | FOLFOX-6 and bevacizumab; irinotecan and cetuximab; cetuximab, bevacizumab and irinotecan |
| 2 | Docetaxel; paclitaxel; anastrozole; capecitabine and gemcitabine |
| 3 | Neoadjuvant FAB; PAC with doxorubicin; TCH, vinorelbine, trastuzumab; gemcitabine, trastuzumab, nab-paclitaxel |
| 4 | FOLFOX and bevacizumab; FOLFIRI with bevacizumab; Cetuximab, irinotecan, and bevacizumab |
| 5 | Cyclophosphamide, methotrexate, and 5-FU; tamoxifen; anastrozole |
| 6 | 5-FU; leucovorin; irinotecan and cetuximab |
| 7 | 5-FU;capecitabine; FOLFOX plus bevacizumab; bevacizumab and oxaliplatin; irinotecan, cetuximab and bevacizumab |
| 8 | 5-FU and leucovorin; irinotecan; FOLFOX-6 and bevacizumab; TRAIL |
| 9 | Irinotecan, 5-FU, leucovorin; FOLFOX and bevacizumab; capecitabine; HAI cisplatin, 5-FU and leucovorin; cetuximab and irinotecan |
| 10 | Imatinib mesylate and letrozole; FEC; capecitabine with docetaxel; nab-paclitaxel and exemestane |
| 11 | Paclitaxel and carboplatin |
| 12 | Gemcitabine and cisplatin; MVAC; ifosfamide, paclitaxel and cisplatin; ATG |
| 13 | Irinotecan; capecitabine; FOLFOX 6; AEE-788; darinaparsin; irinotecan and cetuximab |
| 14 | Adriamycin, DTIC with chemoradiation; gemcitabine; docetaxel; liposomal doxorubicin; imatinib; capecitabine |
| 15 | None |
| 16 | FOLFOX and bevacizumab; FOLFIRI and bevacizumab; irinotecan and Cetuximab; irinotecan, oxaliplatin and cetuximab and bevacizumab; FOLFOX and panitumumab |
| 17 | Carboplatin and paclitaxel; carboplatin; carboplatin and paclitaxel |
| 18 | Sorafenib; gemcitabine and cisplatin; XELOX; FOLFIRI |
| 19 | Docetaxel; carboplatin and irinotecan; gemcitabine and epirubicin |
| 20 | Tamoxifen; anastrozole; exemestane; docetaxel; carboplatin; FAC; Capecitabine; vinorelbine; gemcitabine; bortezomib and bevacizumab |
| 21 | FOLFIRI and cetuximab; FOLFIRI and panitumumab; FOLFIRI and bevacizumab |
| 22 | FOLFOX; FOLFIRI and bevacizumab; cetuximab and irinotecan; FOLFOX |
| 23 | Chlorambucil; leuprolide acetate and bicalutamide; paclitaxel; docetaxel |
| 24 | Chemoembolization of the liver; sorafenib |
| 25 | Doxorubicin and cyclophosphamide; docetaxel; vinorelbine and trastuzumab; capecitabine with lapatinib; nab-paclitaxel and trastuzumab |
| 26 | Doxorubicin, cyclophosphamide, vinblastine, and methotrexate; letrozole and imatinib; docetaxel and capecitabine; vinorelbine; nab-paclitaxel; liposomal doxorubicin; dasatinib and gemcitabine; carboplatin and paclitaxel |
ATG anti-thymocyte globulin; FAC 5-fluorouracil, adriamycin, cyclophosphamide; FOLFOX 5-fluorouracil, folinic acid and oxaliplatin; FOLFIRI 5-fluorouracil, folinic acid and irinotecan; XELOX capecitabine and oxaliplatin